<?xml version='1.0' encoding='UTF-8'?><?xml-stylesheet href="http://www.blogger.com/styles/atom.css" type="text/css"?><feed xmlns='http://www.w3.org/2005/Atom' xmlns:openSearch='http://a9.com/-/spec/opensearchrss/1.0/'><id>tag:blogger.com,1999:blog-2854457536496163901.post4449764593651396416..comments</id><updated>2009-04-25T05:28:48.917-05:00</updated><title type='text'>Comments on Taylorisms: Pharma &amp; Social</title><link rel='http://schemas.google.com/g/2005#feed' type='application/atom+xml' href='http://www.technologyinmarketing.com/feeds/4449764593651396416/comments/default'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/2854457536496163901/4449764593651396416/comments/default'/><link rel='alternate' type='text/html' href='http://www.technologyinmarketing.com/2009/04/pharma-social.html'/><author><name>Mark Taylor</name><uri>http://www.blogger.com/profile/03571313463172712442</uri><email>mark@taylorisms.com</email></author><generator version='7.00' uri='http://www.blogger.com'>Blogger</generator><openSearch:totalResults>1</openSearch:totalResults><openSearch:startIndex>1</openSearch:startIndex><openSearch:itemsPerPage>25</openSearch:itemsPerPage><entry><id>tag:blogger.com,1999:blog-2854457536496163901.post-3501498959180242261</id><published>2009-04-25T05:28:00.000-05:00</published><updated>2009-04-25T05:28:00.000-05:00</updated><title type='text'>Most of this EMEA trip is getting the S&amp;H pharma m...</title><content type='html'>Most of this EMEA trip is getting the S&amp;amp;H pharma marketerers to lose their fear of SM and at least start listening to their brands. I am trying to jostle them out of the inactivity and at least listen. &lt;br /&gt;It was frustrating for me, professionally, with my sector, to be 18 months behind, so enlightenting the company directors to SM, in all its ramifications has been fufilling. Including the research I&amp;#39;ve done on regulations new legal initiatives regarding SM has been helpful as well.</content><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/2854457536496163901/4449764593651396416/comments/default/3501498959180242261'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/2854457536496163901/4449764593651396416/comments/default/3501498959180242261'/><link rel='alternate' type='text/html' href='http://www.technologyinmarketing.com/2009/04/pharma-social.html?showComment=1240655280000#c3501498959180242261' title=''/><author><name>mary</name><uri>http://www.blogger.com/profile/01569607078669672071</uri><email>noreply@blogger.com</email></author><thr:in-reply-to xmlns:thr='http://purl.org/syndication/thread/1.0' href='http://www.technologyinmarketing.com/2009/04/pharma-social.html' ref='tag:blogger.com,1999:blog-2854457536496163901.post-4449764593651396416' source='http://www.blogger.com/feeds/2854457536496163901/posts/default/4449764593651396416' type='text/html'/></entry></feed>